RBC Capital initiated coverage of Siemens Healthineers (SMMNY) with an Outperform rating and EUR 55 price target The firm says the stock’s valuation is not reflective of the company’s medium-term sales and earnings growth potential.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMNY:
- Siemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan Stanley
- Telix, Varian announce strategic collaboration to develop theranostics-EBRT
- Siemens Healthineers downgraded to Neutral from Outperform at BNPP
- Siemens Healthineers downgraded to Hold from Buy at Deutsche Bank
- Siemens Healthineers price target lowered to EUR 58 from EUR 62 at Citi